Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000422875 | SCV000511036 | likely benign | not provided | 2017-01-09 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000422875 | SCV000565605 | benign | not provided | 2019-07-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001089280 | SCV000633889 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311442 | SCV000847269 | benign | Inborn genetic diseases | 2018-12-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000422875 | SCV003917700 | benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | STXBP1: PP2, BS1, BS4 |
Prevention |
RCV004551418 | SCV004758024 | likely benign | STXBP1-related disorder | 2024-05-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |